Lincoln Pharma Share Price

₹ 512.20

+₹12.90 (2.58%)
1D
Last updated 02 Nov, 2026, 15:53 IST
NSE: LINCOLN
|
Pharmaceuticals

Lincoln Pharma Share Price Today

As of 3 Nov 2026, Lincoln Pharma share price is ₹512.20. The stock opened at ₹499.30, compared to its previous close of ₹499.30. During today's trading session, Lincoln Pharma share price moved in the range of ₹499.30 to ₹514.60, with an average price of ₹506.95 for the day. Looking at its last 52-week, the stock has touched a low of ₹440.00 and a high of ₹770.00. On the performance front, Lincoln Pharma share price has declined by 20.69% over the last six months and is down 3.32% on a year-on-year basis.

Share price over the last 1 day rose from 499.30 to 514.60, ranging between 499.30 and 514.60.
₹499.30
2.58% up today
₹514.60
1D LOW
1D HIGH

Lincoln Pharma Stock Insights

Latest Earning
Op Profit TrendUp by 5.90% YoY
Latest Earning
Net Profit TrendUp by 6.73% YoY
Latest Earning
Revenue TrendUp by 9.10% YoY
Stock Performance
OutperformingBeat Nifty by 4.13 % in last 1 year
Shareholding Pattern
PromoterPromoter increased stake by 0.01%
Shareholding Pattern
DIIDII decreased stake by 100.00%
Shareholding Pattern
FIIFII decreased stake by 1.05%
Lincoln Pharma stock performance
Open₹499.30
High₹514.60
Low₹499.30
Prev. close₹499.30
Lincoln Pharma trading activity
Volume27,003
Average traded price₹506.87
Last traded time03:53:10 02 Nov
Last traded quantity1
Circuit
L
H
₹399.45
₹599.15
52-week
L
H
₹440.00
₹770.00
Mkt Cap Cr
1,005.39
P/E
10.38
P/B
1.24
ROA
10.05%
ROE
11.94%
ROCE
15.72%
Quick Ratio
4.53
EV/EBITDA
6.73

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Lincoln Pharma. has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Lincoln Pharma. appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Lincoln Pharma. earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Lincoln Pharma Company Background

ISIN
INE405C01035
Sector Market Cap
₹ 1,005.39 Cr

Lincoln Pharmaceuticals Limited is engaged in the business of manufacturing and trading pharmaceutical products, as well as undertaking contract manufacturing from pharmaceuticals companies across India and the globe. The Company’s product categories include tablets, capsules, liquid injection, cream in tubes, eye/ear drops, dry power injection, SVP injectables, dry-powder suspensions, liquid injection, and pharma products. It offers products for anti-infective, respiratory system, gynecology, cardio and CNS (central nervous system), antibacterial, dermatological infection, anti-diabetic, and anti-malaria. The Company is also engaged in building a portfolio of lifestyle and chronic segments, primarily in women’s healthcare and dermatology. The Company caters to approximately 60 countries in Europe, Latin America, Africa, Asia Pacific, Southeast Asia, and 26 states across India. The Company has two manufacturing facilities located in Mehsana and Khatraj, Gujarat.

Lincoln Pharma Financial Highlights

  • Revenue: Lincoln Pharma reported revenue of ₹704.48 crore in FY26 vs ₹645.71 crore in FY25. It showed an increase of 9.10% on a yearly basis.
  • Operating Profit: Lincoln Pharma reported an operating profit of ₹115.63 crore in FY26 vs ₹109.19 crore in FY25. It showed an increase of 5.90% on a year-on-year basis.
  • Net Profit: Lincoln Pharma reported a net profit of ₹87.89 crore in FY26 vs ₹82.35 crore in FY25. It showed an increase of 6.73% on a yearly basis.

Lincoln Pharma Quarterly Result Highlights

  • Lincoln Pharma reported revenue of ₹200.88 crore in Sep 2026, compared with ₹201.54 crore in Jun 2026, representing a decrease of 0.33% on a quarter-on-quarter (QoQ) basis.
  • Lincoln Pharma reported an operating profit of ₹29.02 crore in Sep 2026, compared with ₹47.55 crore in Jun 2026, representing a decrease of 38.97% on a quarter-on-quarter (QoQ) basis.
  • Lincoln Pharma reported a profit of ₹20.43 crore in Sep 2026, compared with ₹36.23 crore in Jun 2026, reflecting a decrease of 43.61% on a QoQ basis.
  • The earnings per share (EPS) of Lincoln Pharma stood at ₹43.88 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
49.78%
FII
4.55%
Other DII
0.00%
Retail and other
45.67%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20254.70%
Mar 20265.19%
Jun 20264.60%
Sep 20264.55%

Lincoln Pharma Investment Returns

1 day
+2.58%
1 week
-3.22%
1 month
-12.00%
1 year
-3.32%
3 years
-3.84%
5 years
+49.24%

Lincoln Pharma Share Price History

Lincoln Pharma share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹499.30 / ₹512.20
+2.58%
30 Oct 26
₹511.00 / ₹499.30
-2.08%
29 Oct 26
₹561.00 / ₹509.90
-8.64%
28 Oct 26
₹541.00 / ₹558.10
+1.46%
Show more

Lincoln Pharma Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹671.03₹623.23₹580.55₹510.31
Other Income₹33.45₹22.48₹34.42₹22.47
Total Revenue₹704.48₹645.71₹614.97₹532.78
Total Expenses₹588.86₹536.52₹492.73₹432.30
Profit Before Tax₹115.63₹109.19₹122.24₹100.48
Tax₹27.73₹26.84₹28.94₹27.58
Profit After Tax₹87.89₹82.35₹93.30₹72.90
EPS - Basic₹43.88₹41.11₹46.58₹36.40
EPS - Diluted₹43.88₹41.11₹46.58₹36.40

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹115.63₹109.19₹122.24₹100.48
Income before WC changes₹121.94₹110.15₹105.48₹100.25
Change in Assets₹7.08-₹12.20-₹37.43-₹13.13
Change in Liabilities₹2.47₹21.37₹21.32-₹18.25
Change in WC₹9.56₹9.17-₹16.12-₹31.37
Cash flow from Operations₹106.36₹93.02₹63.22₹39.26
Cash flow from Investing-₹98.41-₹78.95-₹57.34-₹36.64
Cash flow from Financing₹0.16-₹6.40-₹5.18-₹4.50
Total Cash Flow₹8.11₹7.67₹0.70-₹1.88
Cash (Start of the year)₹13.41₹5.75₹5.05₹6.93
Cash (End of the year)₹21.53₹13.41₹5.75₹5.05

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹307.35₹297.07₹253.55₹220.21
Current Assets₹583.06₹499.94₹446.74₹367.21
Total Assets₹890.40₹797.01₹700.29₹587.42
Current Liabilities₹111.04₹106.22₹92.28₹72.15
Net Current Asset₹472.01₹393.72₹354.46₹295.07
Non-Current Liabilities₹21.73₹19.12₹15.18₹12.80
Equity Capital₹757.63₹671.67₹592.84₹502.47
Total Equity & Liabilities₹890.40₹797.01₹700.29₹587.42

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹671.03₹623.23₹580.55₹510.31
Other Income₹33.45₹22.48₹34.42₹22.48
Total Revenue₹704.48₹645.71₹614.97₹532.79
Total Expenses₹588.86₹536.52₹492.73₹432.34
Profit Before Tax₹115.63₹109.19₹122.24₹100.46
Tax₹27.73₹26.84₹28.94₹27.56
Profit After Tax₹87.89₹82.35₹93.30₹72.90
EPS - Basic₹43.88₹41.11₹46.58₹36.40
EPS - Diluted₹43.88₹41.11₹46.58₹36.40

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹115.63₹109.19₹122.24₹100.46
Income before WC changes₹121.94₹110.15₹105.49₹100.17
Change in Assets₹7.08-₹12.20-₹37.43-₹13.26
Change in Liabilities₹2.47₹21.37₹21.32-₹18.15
Change in WC₹9.56₹9.17-₹16.12-₹31.40
Cash flow from Operations₹106.36₹93.02₹63.24₹39.16
Cash flow from Investing-₹98.40-₹78.95-₹57.34-₹36.64
Cash flow from Financing₹0.16-₹6.40-₹5.18-₹4.50
Total Cash Flow₹8.12₹7.67₹0.73-₹1.99
Cash (Start of the year)₹12.97₹5.31₹4.58₹6.57
Cash (End of the year)₹21.09₹12.97₹5.31₹4.58

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹307.40₹297.12₹262.56₹220.26
Current Assets₹582.87₹499.75₹437.59₹367.00
Total Assets₹890.26₹796.87₹700.15₹587.26
Current Liabilities₹110.90₹106.08₹92.14₹71.98
Net Current Asset₹471.96₹393.67₹345.45₹295.02
Non-Current Liabilities₹21.73₹19.12₹15.18₹12.80
Equity Capital₹757.63₹671.67₹592.84₹502.47
Total Equity & Liabilities₹890.26₹796.87₹700.15₹587.26
* All values are in INR Crore
Lincoln Pharma market depth
Bid quantityBid priceAsk priceAsk quantity
24512.200
0000
0000
0000
0000
Total bid quantity24
Total ask quantity0
Lincoln Pharma technical summary
Bearish indicators2
Neutral indicators4
Bullish indicators2
OverallNeutral
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
33.46
Neutral
ATR (14)
28.59
Neutral
STOCH(9,6)
7.04
Bullish
STOCH RSI (14)
33.27
Neutral
ADX(9)
45.72
Bearish
UO(9)
45.21
Neutral
ROC(12)
-9
Bearish
WillR(14)
-93.39
Bullish
Period
Simple value
Exponential vaue
5D
529.32
520.37
10D
526.57
528.59
20D
543.33
542.91
50D
583.32
569.67
100D
595.95
588.94
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct4L
28 Oct0L
27 Oct0L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Lincoln Pharma
Pharmaceuticals
Add Stock
Add Another

Lincoln Pharma Returns Calculator

Ex-date: 11 Sep 2026

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

Lincoln Pharma Share Price FAQs

Please be aware that Lincoln Pharma stock prices are subject to continuous fluctuations due to various factors.